Investment
Features
FeesSafety
Academy
More
Pluang+

Shiba Inu burns 1.1 million tokens worth $5 in 24 hours, with mixed longer-term burn trends.

Protocol Fundamentals
19 Oct 2026
Tokenpost
View Source
Neutral
Shiba Inu burns 1.1 million tokens worth $5 in 24 hours, with mixed longer-term burn trends.

Shiba Inu (SHIB) tokens worth about $5 were burned over a 24-hour period ending Oct. 19, totaling 1,097,233 tokens. This daily burn is small compared to the circulating supply of over 585 trillion SHIB tokens. The seven-day burn rate dropped by 83.47%, while the 30-day burn rate increased by 84.73%, showing mixed trends in token burning activity. These figures reflect transfers to a dead address and indicate no clear long-term supply trend from a single day’s data.

Shiba Inu token burn activity is reported with about 1.1 million SHIB tokens burned worth approximately $5 in 24 hours. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Oct 20, 2026 04:42 WIB: 46 out of 50 major cryptocurrencies rose today. EGLD rose 6.13% to Rp64.853, UNI increased 5.66% to Rp130.220, and SNX moved up 5.54% to Rp3.868 with varying Pluang order activity.

More News

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
1 hour ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
1 hour ago
Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...

Company Fundamentals
Bullish
2 hours ago
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Market News
Neutral
3 hours ago
W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App